Implantable Biosensor Capillary Bed Growth for Real-Time Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing implantable biosensors face delays in detecting blood analytes due to the diffusion process from blood to the sensor, which is impeded by the distance and encapsulation in fibrous tissue, leading to delayed detection of concentration variations.

Innovation Solution

A multilayer chip with micromachined capillary holes filled with a gelatinous matrix containing angiogenesis stimulating factors is used to interface directly with the vascular system, promoting the growth of a capillary bed for real-time detection of analytes, allowing diffusional exchange at the same physiological length scale as capillaries.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If direct implantation of biosensors within tissue is used, then the device can be positioned close to blood vessels, but the detection is delayed due to diffusion distance and fibrous tissue encapsulation

Engineering Contradiction:
Improvedetection accuracyVSAvoiddetection delay
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

Instead of having the sensor wait for analytes to diffuse from blood to the sensor surface, the invention inverts the approach by bringing the vascular system (capillaries) directly to the sensor through angiogenesis stimulation. The biosensor actively recruits blood vessels to grow into its porous structure, reversing the traditional diffusion direction and eliminating the time delay associated with molecular diffusion through tissue and fibrous encapsulation layers.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The biosensor incorporates angiogenesis stimulating factors (such as VEGF) into its porous matrix structure before implantation. This preliminary action ensures that capillaries begin growing into the sensor structure immediately upon implantation, establishing direct vascular-sensor contact pathways in advance. This pre-prepared vascular network eliminates the detection delay that would otherwise occur while waiting for natural diffusion processes.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If the sensor is implanted within tissue, then it can be positioned for detection, but fibrous tissue encapsulation impedes diffusion of molecules to the sensor

Engineering Contradiction:
Improvesensor functionalityVSAvoidmolecule diffusion
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The biosensor employs a porous matrix structure with controlled pore sizes that facilitates capillary ingrowth while maintaining sensor functionality. The porous architecture allows capillaries to penetrate deep into the sensor structure, creating direct fluidic pathways that bypass the阻碍 of fibrous tissue encapsulation. This porous design ensures continuous molecule transport from the vascular system to the sensor surfaces throughout the device volume.

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The invention uses angiogenesis stimulating factors as intermediaries to mediate between the biosensor and the vascular system. These factors (embedded in the porous matrix) act as chemical messengers that attract and guide capillary growth toward the sensor, establishing a biological bridge that overcomes the barrier of fibrous tissue encapsulation and ensures reliable molecule diffusion pathways.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Speed

If diffusion distance from blood to sensor is reduced, then detection speed improves, but the sensor structure becomes more complex

Engineering Contradiction:
Improvedetection speedVSAvoidsensor structure
Core Design Contradiction:
SpeedVSDevice complexity

Solution Approach 1:

The biosensor transitions from a traditional planar or surface-mounted architecture to a three-dimensional porous structure that allows capillaries to grow throughout the sensor volume. This dimensional transformation enables analytes to access sensor surfaces from all directions simultaneously, dramatically reducing effective diffusion distances without requiring excessive sensor surface area or complex microfluidic channel systems.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The biosensor structure nests multiple functional elements within its porous matrix: capillaries are recruited to grow within the pores, sensors are embedded throughout the matrix volume, and angiogenesis factors are distributed within the structure. This nested arrangement allows direct vascular-sensor contact at multiple hierarchical levels, reducing diffusion distances while maintaining a relatively compact overall device form factor.

Inventive Principle:
Principle #7Nested doll (Nesting)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables real-time detection of blood analytes by bringing the vascular system to the sensor, reducing detection delays and improving the accuracy and speed of sensing, ensuring that all parts of the biosensor matrix remain within 10-20 μm of the capillary bed for effective diffusional exchange.

Implementation Method 1

a matrix having angiogenesis stimulating factors to stimulate growth of a capillary bed through the biosensor

Methodology Applied
Scientific EffectAngiogenesis:

Implementation Method 2

diffusion of target molecules in blood to the sensors occurs at the same physiological length scale as that from blood in capillaries to the tissue they supply in the body

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS9011330B2Implantable vascular system biosensor with grown capillary beds and uses thereof
Publication Date: 2015.04.21 CALIFORNIA INST OF TECH
  • US9011330B2 patent drawing
  • US9011330B2 patent drawing
  • US9011330B2 patent drawing

AI summary

An implantable biocompatible biosensor is described herein. The biosensor includes a chip layer including a plurality of holes fabricated vertically there through, a power source, one or more sensors on the chip layer and coupled to the power source and a hydrogel matrix including one or more angiogenesis stimulating factors in contact with the chip layer. The stimulating factors stimulate growth of organic material through the plurality of holes when the biosensor is implanted in a subject.